Skip to main content
Canna~Fangled Abstracts

The Medicinal Natural Products of Cannabis sativa Linn.: A Review

By March 4, 2022March 13th, 2022No Comments
Review
. 2022 Mar 4;27(5):1689.

doi: 10.3390/molecules27051689.

Anwuli Endurance Odieka 1, Gloria Ukalina Obuzor 2, Opeoluwa Oyehan Oyedeji 3, Mavuto Gondwe 4, Yiseyon Sunday Hosu 5, Adebola Omowunmi Oyedeji 1
Affiliations 

Abstract

Cannabis sativa is known among many cultures for its medicinal potential. Its complexity contributes to the historical application of various parts of the plant in ethno-medicines and pharmacotherapy. C. sativa has been used for the treatment of rheumatism, epilepsy, asthma, skin burns, pain, the management of sexually transmitted diseases, difficulties during child labor, postpartum hemorrhage, and gastrointestinal activity. However, the use of C. sativa is still limited, and it is illegal in most countries. Thus, this review aims to highlight the biological potential of the plant parts, as well as the techniques for the extraction, isolation, and characterization of C. sativa compounds. The plant produces a unique class of terpenophenolic compounds, called cannabinoids, as well as non-cannabinoid compounds. The exhaustive profiling of bioactive compounds and the chemical characterization and analysis of C. sativa compounds, which modern research has not yet fully achieved, is needed for the consistency, standardization, and the justified application of Cannabis sativa products for therapeutic purposes. Studies on the clinical relevance and applications of cannabinoids and non-cannabinoid phenols in the prevention and treatment of life-threatening diseases is indeed significant. Furthermore, psychoactive cannabinoids, when chemically standardized and administered under medical supervision, can be the legal answer to the use of C. sativa.

Keywords: Cannabis sativa, bioactivity, characterization, extraction methods, medicinal plant, phytochemicals

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1

Figure 2

Figure 2

Figure 3

Figure 3

Figure 4

References

    1. Sofowora A., Ogunbodede E., Onayade A. The role and place of medicinal plants in the strategies for disease prevention. Afr. J. Tradit. Complement. Altern. Med. 2013;10:210–229. doi: 10.4314/ajtcam.v10i5.2. – DOI – PMC – PubMed
    1. Choudhary N., Siddiqui M., Bi S., Khatoon S. Variation in preliminary phytochemicals screening of Cannabis sativa L. leaf, stem and root. Int. J. Pharmacogn. 2014;1:516–519.
    1. Bandar H., Hijazi A., Rammal H., Hachem A., Saad Z., Badran B. Techniques for the extraction of bioactive compounds from Lebanese Urtica Dioica. Am. J. Phytomed. Clin. Ther. 2013;1:507–513.
    1. Andre C.M., Hausman J.F., Guerriero G. Cannabis sativa: The plant of the thousand and one molecules. Front. Plant Sci. 2016;7:19. doi: 10.3389/fpls.2016.00019. – DOI – PMC – PubMed
    1. Elsohly M.A., Radwan M.M., Gul W., Chandra S., Galal A. Phytochemistry of Cannabis sativa L. Phytocannabinoids. 2017;103:1–36.

Publication types

Leave a Reply